Comparison of the HAS‐BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct‐acting oral anticoagulants

Atrial fibrillation: diagnosis and management—summary of NICE guidance

(2021) Mark Perry et al.   BMJ-British Medical Journal

Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial

(2020) Yutao Guo et al.   AMERICAN JOURNAL OF MEDICINE

Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry

(2020) Rungroj Krittayaphong et al.   Journal of Clinical Medicine

Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand

(2020) Phannita Wattanaruengchai et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Changes in Oral Anticoagulation Therapy over One Year in 51,000 Atrial Fibrillation Patients at Risk for Stroke: A Practice-Derived Study

(2019) Stefan Hohnloser et al.   THROMBOSIS AND HAEMOSTASIS

Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon in Geriatric and Non-Geriatric Patients with Non-Valvular Atrial Fibrillation

(2019) Christopher Hohmann et al.   THROMBOSIS AND HAEMOSTASIS

Incidence, risk factors, and outcomes of warfarin‐associated major bleeding in Thai population

(2019) Watcharapong Priksri et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

External Validation of the ORBIT Bleeding Score and the HAS-BLED Score in Nonvalvular Atrial Fibrillation Patients Using Direct Oral Anticoagulants (Asian Data from the DIRECT Registry)

(2019) Naoki Mori et al.   AMERICAN JOURNAL OF CARDIOLOGY

Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors

(2018) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic Therapy for Atrial Fibrillation

(2018) Gregory Y.H. Lip et al.   CHEST

Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants

(2017) S. A. Beshir et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation

(2017) George Ntaios et al.   STROKE

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPACE

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores

(2016) G. Y. H. Lip et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

(2016) Sylvia Haas et al.   PLoS One

Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project

(2016) Yu-tao Guo et al.   Scientific Reports

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal

(2015) Gregory Y.H. Lip et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation

(2015) Kang-Ling Wang et al.   STROKE

Stroke prevention in atrial fibrillation—An Asian stroke perspective

(2013) Hung-Fat Tse et al.   HEART RHYTHM

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study

(2013) Rikke Sørensen et al.   BMJ Open

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Assessing the Performance of Prediction Models

(2009) Ewout W. Steyerberg et al.   EPIDEMIOLOGY